Crucial European Parliament vote vastly improves SPC manufacturing waiver

23 January 2019

Medicines for Europe welcomes today’s vote of the Legal Committee […]

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

The Medicines for Europe Board unanimously applauds last night’s vote […]

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Yesterday, 29th November, members of the Competitiveness Council expressed strong […]

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

The introduction of comprehensive SPC manufacturing waiver key to unlocking […]

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

The European Commission and OECD – Health at a Glance: […]

Driving local excellence, delivering European results

5 November 2018

Medicines for Europe is glad to announce the occasion of […]

Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers

11 October 2018

There is a concrete risk that disproportionate influence on the […]

CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court

20 September 2018

An English Court has determined that the contested supplementary protection […]

Newsroom

News about

By type

Twitter

Videos

Photos

Crucial European Parliament vote vastly improves SPC manufacturing waiver

23 January 2019

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

Driving local excellence, delivering European results

5 November 2018

Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers

11 October 2018

CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court

20 September 2018

SPC manufacturing waiver is good news for Europe

19 September 2018

Subscribe to our newsletter